The UK Health Security Agency (UKHSA) has identified 24 infectious diseases that pose the greatest future threats to public health. Some, like COVID-19, have pandemic ...

Clover Biopharma receives IND clearance from US FDA and begins revaccination clinical study for RSV vaccine candidate SCB-1019: Shanghai Tuesday, March 25, 2025, 16:00 Hrs [IST] C ...

U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019) ...

In recent weeks, I have received calls, texts, and WhatsApp messages from several understandably concerned parents about ...

As a result of the recognition of the increased impact of these viruses, new vaccines and therapeutic options have been and ...

Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have been assigned an average rating of “Hold” from the twenty-four ...

Moderna (NASDAQ:MRNA – Get Free Report) had its price objective lowered by analysts at JPMorgan Chase & Co. from $40.00 to ...

The largest of the collaborations is a potentially more than $4.68 billion partnership with Shanghai-based Harbour BioMed to ...

“Seasonal influenza, COVID-19, respiratory syncytial virus (RSV), and other common respiratory viruses such as human metapneumovirus (hMPV) and mycoplasma pneumoniae remain circulating,” he explained.

Although the respiratory season in Hungary has eased for the second week in a row, there were still almost 100 children under ...

Historically, RSV has been studied mainly in infants and older adults, but recent research shows that it also poses a ...